Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Clinical trial NCT05257993 · RECRUITING
Trial details
- NCT number
- NCT05257993
- Sponsor
- Onconic Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2030-04-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.